A strategic partner for next-gen materials teams

About Jenny Erwin
I help biomaterials innovators navigate the gap between visibility and proof, ensuring the story they tell externally is matched by the capabilities they are building internally.

My work focuses on ingredient branding, market positioning, adoption pathways, and the credibility dynamics that shape whether materials succeed or stall.


How I Work

I blend:

  • strategic marketing

  • market research

  • consumer behavior

  • material-category dynamics

  • ecosystem mapping

  • early-stage go-to-market logic

My approach is analytical but narrative-driven: translating complex material science realities into strategic clarity for investors, brand partners, and internal teams.

What I Bring

  • Master’s research on cell-cultured leather adoption in performance-critical luxury category

  • Frameworks referenced by founders, VCs, and innovation teams

  • Experience collaborating with companies across the biomaterials landscape

  • A cross-disciplinary lens spanning marketing, material futures, branding, and product-market fit

Who I Partner With

  • early-stage biomaterials start-ups

  • growth-stage ingredient brands

  • VCs seeking category intelligence

  • teams navigating scale, credibility, and market entry

My Philosophy
I’m drawn to the space where data, strategy, and human behavior meet. My work centers on understanding why people think the way they do, not just what the survey results say, and translating that into clear, evidence-based strategy. I believe that strong decisions come from asking better questions, stress-testing assumptions, and making the complex intelligible.

Why Biomaterials
My interest in biomaterials started long before I knew the term. As a lifelong equestrian, I’ve watched how deeply performance and tradition shape material expectations: leather is trusted because it lasts, adapts, and performs under pressure. Synthetic alternatives entered the market, but their different feel and durability created an immediate stigma.


So the question that has stayed with me is: What would it take for a new material to be accepted in a category where performance can’t be compromised?

I’m drawn to biomaterials because the science is genuinely fascinating…watching entirely new classes of materials emerge in real time is something rare in any industry. But what motivates me even more is the challenge of making those breakthroughs understandable, credible, and strategically viable. I love research, pattern recognition, and turning complexity into clarity. My background in consumer insight, marketing strategy, and long-term category analysis lets me connect scientific potential to real-world adoption. Biomaterials are where innovation, behavior, and market architecture collide, and that’s exactly where my brain does its best work.